Acorda Therapeutics, Inc.
METHODS FOR CARDIOMYOCYTE SURVIVAL, PROLIFERATION OR DIFFERENTIATION BY NRG-2
Last updated:
Abstract:
The invention features methods of treatment and diagnosis using NRG-2 polypeptides, nucleic acid molecules, and antibodies. The invention also provides novel NRG-2 polypeptides and nucleic acid molecules.
Status:
Application
Type:
Utility
Filling date:
5 Jun 2020
Issue date:
12 Nov 2020